Founded in July 2012, Bontac Bio-Engineering (Shenzhen) Co., Ltd. (hereafter referred to as BONTAC) is a high-tech enterprise integrating R&D, production and sales, with enzyme catalysis as the core biosynthetic technology. There are six major series of products in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates.
As the leader of the global NMN industry, BONTAC has the first whole-enzyme catalysis technology in China. Our coenzyme products are widely used in fields such as nutrition and health, biomedicine, medical beauty, daily chemical and green agriculture.
BONTAC adheres to independent innovation, with more than 180 invention patents. BONTAC has undertaken lots of government key technology projects at provincial and municipal level. What’s more, BONTAC has established the first coenzyme engineering technology research center at the provincial level in China which also is the sole in Guangdong Province.
BONTAC will focus on its advantages of green, low-carbon and high-value-added biosynthesis technology, and build ecological relationship with academia as well as upstream/downstream partners, continuously leading the synthetic biological industry and creating a better life for human beings.
Green Biotechnology, Healthier and Better Life
Green biotechnology, healthier and better life.
To provide superior-quality healthy raw materials for worldwide enterprises
The first to launch NMN mass production worldwide
We have more than 35 people, including 5 PhDs and 10 masters. We have recruited or cultivated 6 high-level talents in Shenzhen, including 1 local-level leading talent and 5 category C talents in the Peacock Program. We have established cooperative relations with the Institute of Chemistry, Chinese Academy of Sciences, Shenzhen Advanced Institute of Chinese Academy of Sciences, China Academy of Chinese Medical Sciences, Peking University Shenzhen Graduate School, Southern University of Science and Technology, Shenzhen University, Hubei University and other research institutes.
Under the leadership of the founder team, a total of 110 Bontac family members have been honed in the past 9 years, including 38 members of enzyme catalysis R&D team, 67 members of the industrial production/sales team, and 5 members of the biotechnology senior management team.
Chief Scientist
Dr. Cheung, the chief scientist and founder of BONTAC, was once engaged in research work at the Institute of Genetics and Developmental Biology in Chinese Academy of Sciences, Cornell University and City University of Hong Kong. She has been dedicated to the application of biological enzyme catalysis technology into the green bio-manufacturing industrialization of coenzymes, medical intermediates and natural products for over 20 years. Notably, Dr. Cheung has applied approximately 90 invention patents at home and abroad, authorized over 60 patents and conducted key R&D plan projects in Guangdong province as well as key science and technology projects in Shenzhen city.
